Dr. Kami Parsa

“My goal has always been to provide compassionate care and achieve natural results for my patients, offering the latest treatments available,” says Dr. Kami Parsa.

BEVERLY HILLS, Calif. (PRWEB)
July 07, 2023

Dr. Kami Parsa, a highly-credentialed oculoplastic and reconstructive surgeon in Beverly Hills, has recently been recognized as a Top Patient Rated Doctor by Find Local Doctors. His patient-centered approach and expert knowledge in oculoplastic procedures have fostered a large volume of outstanding reviews from his patients across multiple online sources. Such superior ratings have led Find Local Doctors, a credible online directory of medical providers, to honor Dr. Kami Parsa with this award. Dr. Parsa is a skilled oculoplastic surgeon who is highly sought-after for his specialization in reconstructive, revisional and cosmetic surgery of the eyes and surrounding tissue. He is known for excellence in cosmetic eyelid surgery, upper eyelid lifts, and minimally-invasive surgical techniques. As a double-board-certified ophthalmologist and oculofacial plastic surgeon, Dr. Parsa is renowned for his artistic approach and meticulous attention to detail.

Over the course of his career, Dr. Kami Parsa has performed thousands of procedures to help patients achieve a refreshed and rejuvenated appearance. He is known across the country for his expertise and has earned numerous awards as a leading Beverly Hills oculoplastic surgeon, appearing on multiple media outlets, such as The Doctors, Botched, The New York Times and the Miami Herald. While Dr. Parsa holds elite qualifications and experience in his field, he passionately pursues new innovative techniques to produce beautiful results with minimal downtime for his patients. Offering cosmetic procedures such as blepharoplasty (eyelid lift) and eyebrow lifts, Dr. Parsa also performs a full menu of complex reconstructive surgeries for the eyes, including those involving ectropion repair, orbital decompression and Bell’s Palsy. In addition, at his Beverly Hills practice patients can take advantage of non-surgical treatments in facial rejuvenation using fillers, lasers, micro needling and more.

“My goal has always been to provide compassionate care and achieve natural results for my patients, offering the latest treatments available,” says Dr. Kami Parsa.

More about Dr. Kami Parsa:

Kami Parsa M.D. is a native of California. He attended UCLA and graduated with honors from the University of Southern California School of Medicine. Dr. Parsa completed a residency in ophthalmology at USC’s prestigious Doheny Eye Institute. He then finished a two-year sub-specialty fellowship in Oculoplastic & Reconstructive Surgery at the University of Miami’s Bascom Palmer Eye Institute. Dr. Parsa participates in several humanitarian efforts and is a member of the American Academy of Ophthalmology and fellowship trained by the American Society of Ophthalmic Plastic & Reconstructive Surgeons. He is also a clinical professor at USC’s Department of Ophthalmology and Department of Plastic Surgery and has published extensively in leading medical journals and textbooks. Dr. Parsa frequently lectures at major meetings and conferences around the world. For more information about the cosmetic and reconstructive services offered by Dr. Kami Parsa, please call his clinic located at 465 N Roxbury Dr. Suite 1011 in Beverly Hills, CA, at (310) 777-8880 or visit his website at http://www.oculoplastic.info.

Share article on social media or email:

Allegheny Health Network, Israel Innovation Authority Announce Plans for Technology Start-Up Collaboration

“Health care is local, but health care research is global — and international partnerships are an important part of our targeted research strategy at AHN and Highmark Health,” said Keith Lejeune, AHN’s Senior Vice President for Research and Innovation.

PITTSBURGH (PRWEB)
July 07, 2023

Allegheny Health Network (AHN) and the Israel Innovation Authority announced today that they have signed a memorandum of understanding to establish a formal affiliation between AHN’s Research Institute and the Innovation Authority to support Israeli health-care startups, and provide them with access to AHN facilities for pilot projects, advanced technology support, and other forms of program assistance.

When launched, the organizations will collaborate on an array of technologies and business development opportunities that have the potential to bring some of Israel’s most promising health technology startups to Pittsburgh, giving the companies — and the entrepreneurs behind them — a local research partner and a foothold for American operations.

“We’re excited to partner with the Israel Innovation Authority to help cultivate some of their country’s brightest health care startups, and we’re thrilled to work with their entrepreneurs as they refine, test and scale innovative new technologies that may one day benefit patients and medical providers here in Pittsburgh, and around the world,” said Tariq J. Cheema, MD, medical director of the AHN Research Institute. AHN, based in Pittsburgh, Pennsylvania, is a 14-hospital health care organization and part of Highmark Health.

After the collaboration is finalized later this year, applications to the program will be opened in Israel, with the Innovation Authority and the AHN Research Institute jointly selecting, screening and approving finalists. The selected companies will then receive up to 50% funding from the Israel Innovation Authority for conducting joint research and development projects or pilots together with AHN.

The AHN Research Institute may also choose to supply its own seed funding, in addition to non-monetary support such as access to AHN facilities, consulting services, research assistance, information technology assistance, and clinical and administrative staff across a variety of clinical settings, for the purposes of piloting new technologies or even new drug therapies.

“The ability to develop a drug suitable for a particular population, to ensure its safety, and to prove its efficacy with precision, is paving the way for faster, smarter, and cost-effective medical care,” said Dr. Amiram Appelbaum, Chairman of the Israel Innovation Authority and Chief Innovation Scientist at the Ministry of Innovation, Science and Technology. “We are delighted to collaborate with an outstanding partner such as AHN, which has a rich legacy of advancing pioneering scientific research and groundbreaking clinical innovations that have improved the health and well-being of so many people over the decades.”

This collaboration will be part of the Innovation Authority’s larger International Health Centers R&D and Piloting program, which established similar partnerships with the Mayo Clinic, Hartford HealthCare and Thomas Jefferson University Hospitals in the U.S., as well as hospitals in the United Kingdom and Germany.

This new collaboration “will enable the Israeli medical innovation ecosystem to access top-tier facilities, know-how, infrastructure and expertise on a global scale, and provide Israeli companies with a new launchpad for their technologies and services,” Dr. Appelbaum said.

AHN, meanwhile, continues to expand its portfolio of partnerships with international collaborators. In recent months, AHN has formalized agreements with Splendo Health (Netherlands) and AdipoPharma (France) to share office space, lab space and professional resources at AHN Suburban, a former acute-care hospital in Bellevue, Pa., that is now being used as a health care innovation center.

AHN Suburban is also home to AlphaLab Health, a life-sciences incubator that was developed in partnership with Pittsburgh-based technology investor Innovation Works.

The AlphaLab Health incubator draws applicants from around the world to compete for pre-seed investment funding and participate in a mentorship program that helps them to navigate the key risk points in the clinical and commercial development of their early-stage companies.

“Health care is local, but health care research is global — and international partnerships are an important part of our targeted research strategy at AHN and Highmark Health,” said Keith Lejeune, AHN’s Senior Vice President for Research and Innovation. “These strategic alliances will be key as we work to nurture new health care technologies and companies that will help to solve the many systemic challenges that affect the U.S. and global health care systems.”

AHN’s partnership with the Innovation Authority is the latest in a series of collaborations between Pittsburgh-based innovators and their Israeli counterparts. For example, the group known as “412×972” — signifying the area code for Pittsburgh and the international calling code for Israel — has nurtured business connections between the two regions, and has helped dozens of Israeli and Pittsburgh companies partner on innovative projects since 2020.

AHN has been a participant in the 412×972 initiative from the beginning.

AHN Suburban is also home to Testa Seat, a company that builds adaptive seating for children and adults with special needs. Founded in Israel by Alex Geht, Testa Seat is part of AHN Suburban’s disability technology incubator program, and arrived in Pittsburgh through an Israeli initiative known as TOM — Tikkun Olam Makers.

TOM, a global nonprofit founded by Israeli entrepreneur Gidi Grinstein, sponsors companies that create affordable technologies and products for people living with disabilities, as well as the elderly and the poor. (Tikkun olam is the core Jewish concept of “repairing the world” through purposeful service and action.)

“Our agreement with the Israel Innovation Authority is the latest example of how AHN is seeking out partners locally and internationally who share our mission and values,” said Jeffrey Cohen, MD, Chief Physician Executive, Community Health and Innovation for AHN and leader of AHN Suburban. “Working together with the IIA, we can develop new technologies and solutions that further advance our Living Health strategy by helping marginalized populations, building stronger communities, and improving the lives of our patients and others around the world.”

###

About the Israel Innovation Authority

The Israel Innovation Authority, an independent publicly funded agency, was created to provide a variety of practical tools and funding platforms aimed at effectively addressing the dynamic and changing needs of the local and international innovation ecosystems. This includes early-stage entrepreneurs, mature companies developing new products or manufacturing processes, academic groups seeking to transfer their research developments to the market, global corporations interested in collaborating with Israeli technology, Israeli companies seeking new markets abroad and traditional factories and plants seeking to incorporate innovative and advanced manufacturing into their businesses. For more information, visit The Israel Innovation Authority | Israel Innovation (innovationisrael.org.il/en).

About the Allegheny Health Network

Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 22,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Patina Health

Designed specifically for older adults, Patina meets individuals on their terms through a convenient and highly personalized model that includes virtual care visits and in-home visits when needed.

CHARLOTTE, N.C. (PRWEB)
July 07, 2023

Patina, a relationship-centered primary care provider dedicated to improving the healthcare and aging experience for people 65 and older, is expanding to serve members enrolled in participating Medicare Advantage plans across the Charlotte region beginning in July. Patina primary care is available at no extra cost to more than 100,000 people who participate in Aetna, Cigna Healthcare and UnitedHealthcare Medicare Advantage plans across the following 10 counties in North and South Carolina: Mecklenburg, Union, Gaston, Cabarrus, York, Chester, Lancaster, Lincoln, Iredell and Rowan counties.

Designed specifically for older adults, Patina meets individuals on their terms through a convenient and highly personalized model that includes virtual care visits and in-home visits when needed. This eliminates the need for patients to drive, park and wait for primary care appointments and makes Patina’s primary care experience accessible to anyone in the 10-county area.

“We’ve flipped the traditional primary care model on its head to give older adults the kind of primary care experience they deserve – one where they are truly seen and heard and, most importantly, have the opportunity to live their best lives and age independently at home,” says Patina CEO Jack Stoddard. “By taking a proactive approach that meets patients on their own terms, we get to really understand who they are and provide personalized care that’s aligned with their unique values, preferences and goals. We are excited to partner with leading health plans to serve new patients across the Charlotte area.”

Click here to hear Patina CEO Jack Stoddard describe Patina.

Every Patina patient is assigned a dedicated team that includes a primary care practitioner and Patina Health Champion, who serves as the go-to resource to help with legwork, navigating the complex healthcare system, coordinating care and connecting individuals to valuable community and health plan resources. Patina also makes it easy for patients’ family members and loved ones to participate in care planning and visits.

“Primary care should function as your partner, helping you to lead care for your total health, making sure your needs are met and that your values and preferences are followed over time,” says Neil Patel, M.D., Patina’s Chief Health Officer. “This is why Patina takes the time to build deep, trusted relationships with every patient we serve, so they can receive the dignity, empathy and care that they deserve.”

Click here to hear a real Patina patient describe their experience.

Charlotte area residents 65+ and their loved ones can learn more about Patina at patinahealth.com or 855.478.8310.

###

About Patina

Patina™ is reinventing primary care from the ground up to provide the healthcare and aging experience that older adults and their loved ones deserve. Each person we serve gets a dedicated care team built around them composed of primary care clinicians, a health champion and behavioral health and other specialists – all enabled by purpose-built technology and analytics. As a value-based primary care model, we are focused on delivering a high-quality, high-value experience to the people we serve.

Patina is a collaboration between two entities: The first is Patina Medical Group, P.C. (PMG-CAR), a virtual and home-based medical practice that provides clinical services to members of certain Medicare Advantage plans, and Patina Health, Inc., which provides administrative and management services to support PMG’s business operations and non-clinical quality assurance, as well as advanced information technology and products, population health analytics and thought leadership.

For more information about Patina visit https://patinahealth.com.

Media Contacts:

Charlotte

Kelsey Dixon

704.942.7248

kdixon@thebrandonagency.com

National

Aimee Eichelberger

312.952.1528

Aimee@superior.com

Share article on social media or email:

M&S Smart System® VR Headset

We are excited about the potential applications for this device and look forward to the M&S VR headset helping patients who otherwise could not or would not receive needed testing.

NILES, Ill. (PRWEB)
July 07, 2023

Researchers at the University of Iowa Carver College of Medicine and the Department of Ophthalmology and Visual Sciences recently completed a pilot study showing that a virtual reality headset can be used to reliably diagnose and monitor visual field loss in glaucoma patients. This study paves the way for wider adoption of such headsets, which will not only make testing quicker and more comfortable, but also more accessible for patients with mobility issues. This in turn would mean better screening and early detection of glaucoma in vulnerable parts of the population.

The study was conducted by two University of Iowa researchers who compared performance of a Smart System Virtual Reality Perimeter (SSVR) from M&S Technologies with a more traditional testing device, the Humphrey Field Analyzer (HFA). The HFA is a large device that does not allow for examination outside the clinic, and which “can be uncomfortable for patients with limited mobility or large body habitus.” Contrastingly, the SSVR is a head-mounted device that many users are already familiar with through other contexts, such as gaming.

The study looked at a population of adult patients diagnosed with glaucoma or suspected of having early glaucoma. Each patient completed visual field tests with both devices in a random order. Test results indicate that the SSVR was just as reliable as the HFA for testing purposes, especially as glaucoma severity increases. Test duration was also shorter in all cases, and the majority of participants tested said that they preferred the SSVR over the HFA when it came to the visual field testing experience.

“We were thrilled to learn not only that the headset performed well, but that patients preferred it,” says Mike Umali, National Sales Manager for M&S Technologies, makers of the Smart System and SSVR. “Whenever you can make testing more comfortable for patients while maintaining accuracy, it’s a win for everyone—doctors, patients, and device makers.”

The M&S SSVR is commercially available for use in visual field testing as well as numerous functional tests. M&S continues to evaluate new tests to determine which vision tests can be accurately adapted to the virtual reality headset platform.

“The goal is to equip practitioners with another tool they can use to help patients,” says Umali. “We are excited about the potential applications for this device and look forward to the M&S VR headset helping patients who otherwise could not or would not receive needed testing.”

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 6 million people worldwide blind due to the disease and another 13 million suffering from moderate to severe visual impairment. Many of the same studies that derive these estimates also show that glaucoma can be avoided with early detection and timely intervention.

About M&S Technologies: Founded in 1990, M&S Technologies is a software development and device manufacturer, rooted in state-of-the-art software development, local manufacturing, and superior customer service. M&S is known worldwide for leading technological advancements in visual testing systems. M&S is dedicated to bringing high quality, extremely accurate testing products to eye care professionals, optometry schools, and universities.

For more information, please visit http://www.mstech-eyes.com/vr-headset.

Share article on social media or email:

Allergist says that most who think they are allergic to penicillin are likely not and are limiting their access to medications.

“We now know that if someone has not been exposed to penicillin in over five years, there is about an 80% chance that the allergy is out of their system,” says Luis Saca, MD.

LOMA LINDA, Calif. (PRWEB)
July 06, 2023

Many people think they’re allergic to penicillin, but experts say most of the population is not allergic at all. Allergist and immunologist Luis Saca, MD, implemented a new program at Loma Linda University Health to test for patients’ penicillin allergy and hopefully decrease the unnecessary use of broad-spectrum antibiotics.

According to the CDC, approximately 10% of U.S. patients report having a penicillin allergy. Realistically, however, fewer than 1% of the population is truly allergic to penicillin, as noted in the same CDC report. This allergy limits an individual’s access to many beneficial medications that are penicillin derivatives. Penicillin allergy patients must take broad-spectrum antibiotics that can increase healthcare costs and antibiotic resistance.

Saca says reactions to the drug in childhood cause many individuals to think they are allergic through adulthood. “The allergic reaction is not for life,” he says. “We now know that if someone has not been exposed to penicillin in over five years, there is about an 80% chance that the allergy is out of their system.”

Many patients also experience side effects and label it an allergy. Nausea, vomiting, and abdominal pain are just a few common side effects — not allergic reactions. Someone experiencing a true allergic reaction to penicillin may have a cough, shortness of breath, itchiness, or a rash. These are indicators of a type-1 hypersensitivity reaction in someone whose immune system developed an IgE antibody against a soluble antigen (eg., penicillin).

Saca says referrals to allergy and immunology will receive a progressive three-step test in one doctor’s visit.

1. Skin prick test. A positive reaction indicating an allergy will cause a red, itchy, raised bump. Patients with no reaction move to the next step.

2. Intradermal test. The faculty will then inject a small amount of solution under the skin of the forearm to create a small bump. Growth indicates a positive reaction. The patient will move to the final test if no growth is observed.

3. Oral test. Patients will receive amoxicillin in the office and are closely monitored by faculty for 45 to 60 minutes. Saca says if the first two tests are negative, the oral test is likely also negative.

Receiving negative results for all tests allows Saca to remove the penicillin allergy from the patient’s chart and restore their healthcare options.

To find out if your penicillin allergy is no longer in your system, make an appointment with your primary care doctor and ask for a referral to Allergy and Immunology. To schedule an interview with subject matter experts on this topic, please contact Molly Smith at mollysmith@llu.edu.

Share article on social media or email:

NexGen Health

SAN JOSE, Calif. (PRWEB)
July 06, 2023

At NexGen Health, their mission is to provide valued patients with the latest advancements in healthcare and aesthetics and are thrilled to offer Morpheus8 as a non-surgical solution for facial rejuvenation. The Morpheus8 treatment is a breakthrough in the world of aesthetic medicine, offering patients a non-invasive alternative to traditional surgical procedures. By stimulating collagen production deep within the skin, Morpheus8 helps reduce the appearance of wrinkles, fine lines, acne scars and other skin imperfections. In addition, this innovative procedure can effectively contour the face, providing lift and definition to sagging or loose skin. With its impressive results and minimal downtime, Morpheus8 has quickly become a game-changer in the field of aesthetic medicine. The key advantage of Morpheus8 lies in its ability to target the deeper layers of the skin with precision and control. This makes it suitable for all skin types and allows for customized treatment plans tailored to each individual’s unique needs. The procedure can be performed on various areas, including the face, neck and body, offering versatility to address a wide range of aesthetic concerns. NexGen Health takes pride in its team of experienced and highly skilled medical professionals who have undergone extensive training in performing Morpheus8 treatments. Their expertise, coupled with the state-of-the-art facility, ensures that patients receive the highest standard of care in a comfortable and safe environment.

“We are committed to delivering exceptional results and personalized treatment plans to our clients. With Morpheus8, we can help our patients achieve natural-looking rejuvenation, enhancing their confidence and well-being,” says Dr. James Petros

More about NexGen Health:

The team at NexGen Health includes board certified physicians and other medical professionals that are dedicated to improving wellness for patients. They offer nutrient deficiency and genetic testing to determine the best supplementation to achieve improved health. If you want to improve your energy, health and overall well-being, consider the benefits of targeted IV infusion, hydration therapy, boosters and other therapies offered at this clinic. NexGen Health serves patients from their office located at 1610 Blossom Hill Rd, Suite 10, in San Jose, CA, and offers concierge medicine for a fee. To schedule a consultation please visit http://www.mynexgenhealth.com or call 408-400-2967.

Share article on social media or email:

American College of Lifestyle Medicine

The results of this research are highly encouraging because clinician burnout is a growing problem that can not only impact the clinician’s sense of wellbeing but also the safety and quality of care that patients receive

ST. LOUIS, Mo. (PRWEB)
July 06, 2023

A research study just published in the American Journal of Health Promotion found that the more that lifestyle medicine clinicians were able to incorporate lifestyle medicine into their medical practices, the less likely they were to experience burnout.

Practicing more lifestyle medicine was associated with a 43% decrease in the chances of experiencing burnout in this 2019 cross-sectional survey of 482 members of the American College of Lifestyle Medicine (ACLM).

Additionally, 90% of respondents reported that lifestyle medicine positively impacted their professional satisfaction. Of these, 44% attributed that positive impact to feelings of accomplishment and meaningfulness, 26% to increased patient satisfaction due to improved outcomes, and 22% to enjoyment of teaching and coaching leading to more personal clinician-patient relationships.

Burnout among health professionals is an urgent national problem, with an estimated 63% percent of health care professionals experiencing it in 2022, up from 44% in 2017. Some are leaving the already short-staffed medical profession because of it. The Association of American Medical Colleges projects a physician shortage of between 37,800 and 124,000 by 2034.

Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes, and obesity. Lifestyle medicine certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions. Applying the six pillars of lifestyle medicine—a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connections—also provides effective prevention for these conditions.

Almost two-thirds of survey respondents were allopathic (MD) or osteopathic physicians (DO). Other respondents included registered nurses, registered dietitians, physical therapists, occupational therapists and doctors of nursing practice. Importantly, 28% of respondents reported no longer experiencing burn out. Of those, 84% attributed it to changing their work situation. Among those, 43% said the opportunity to better incorporate lifestyle medicine into their practice motivated their job change.

One respondent wrote that lifestyle medicine “is aligned with my purpose, so provides satisfaction. I get time with patients and can address emotional/spiritual issues in addition to physical complaints, thus addressing the whole person.” Another respondent wrote that “Lifestyle medicine practice has brought joy and meaning to my professional work” while another reported gratitude in “being able to offer a way to avoid or reverse chronic disease rather than simply moving chairs around on the deck of the Titanic.”

Improved self-care, such as incorporating lifestyle behavior changes into their own lives, was also a top reason reported for reduced experiences of burnout. One respondent wrote “I also implemented my own lifestyle medicine changes – increased physical activity, switched to plant-based diet, managed stress better.”

ACLM offers a Physician and Healthcare Professional Well-Being course to support health professionals in achieving and sustaining healthy lifestyles. The course includes exercises to harness personal strengths and leadership skills for improving workplace culture and to engage in effective, positive patient interactions.

The study notes that attempts to reduce clinician burnout have traditionally focused on organizational changes related to staffing, paperwork or reduced rotations, but have produced only modest results. This is the first study to explore the experiences of burnout and, most importantly, reductions in burnout among lifestyle medicine clinicians. Future research should examine and compare the experiences of burnout among lifestyle medicine clinicians and similar groups of non-lifestyle medicine clinicians, the study stated.

Lifestyle medicine has also been identified as a potential strategy to inspire student doctors to choose a primary care specialty through an increased focus on nutrition, physical activity and other lifestyle modifications in medical education. The shortage of primary care physicians alone is projected to grow to between 17,800 and 48,000 by 2034.

“The results of this research are highly encouraging because clinician burnout is a growing problem that can not only impact the clinician’s sense of wellbeing but also the safety and quality of care that patients receive,” said ACLM President Beth Frates, MD, FACLM, DipABLM, clinical assistant professor at Harvard Medical School. “It appears that a primary driver of burnout is a profound lack of satisfaction and joy in the lives of clinicians who are asked to manage patients with increasing numbers of chronic conditions through ever-increasing quantities of medications and procedures. Lifestyle medicine allows clinicians to connect on a deeper level with patients and address the root causes of disease to help them truly heal. And the opportunity to be true healers is why many clinicians choose to study medicine in the first place.”

ABOUT ACLM

The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management.

Share article on social media or email:

AmeriCare Medical, Inc. provides integrated health services to hospitals, insurance companies, assisted care facilities and private clients throughout Michigan.

“AmeriCare and our subsidiaries are committed to providing quality healthcare throughout its patient-focused services, as validated by the Community Health Accreditation Partner (CHAP), the number one, national accrediting agency for post-acute care,” stated Greg Jamian, President and CEO.

TROY, Mich. (PRWEB)
July 06, 2023

The Community Health Accreditation Partner (CHAP) announced that AmeriCare Medical, Inc. has been awarded CHAP accreditation under the CHAP Standards of Excellence for home health and pharmacy providers. AmeriCare Medical has consistently received national accreditation over the past 30 years, solidifying its position as a trusted leader in the healthcare industry.

“AmeriCare and our subsidiaries are committed to providing quality healthcare throughout its patient-focused services, as validated by the Community Health Accreditation Partner (CHAP), the number one, national accrediting agency for post-acute care,” stated Greg Jamian, President and CEO.

AmeriCare Medical, and its subsidiaries, AmeriStaff Nursing Services, Rx iV Infusion Pharmacy and Sun Medical Equipment Company, offer a comprehensive range of integrated health services across Michigan. Working with hospitals, insurance companies, assisted care facilities, and private clients, its range of services help to ensure that clients receive personalized care across diverse healthcare needs.

Jamian added, “our high intention, sincere effort, intelligent direction and skillful execution of quality initiatives, separates us from all other competitors”.

Established in 1965, CHAP was the first organization to recognize the value of and need for home and community-based care standards and accreditation. As an approved accreditor by the Centers for Medicare & Medicaid Services (CMS), CHAP assists healthcare agencies in maintaining ongoing quality, achieving sustainable growth, and ensuring compliance with industry regulations.

AmeriCare Medical’s achievement of CHAP accreditation signifies the company’s unwavering commitment to upholding the highest industry standards for care.

For more information, visit https://chapinc.org/

About AmeriCare Medical, Inc.

For more than three decades AmeriCare Medical, Inc. has provided integrated healthcare services to hospitals, assisted care facilities, and private homes throughout Michigan. AmeriCare Medical, Inc. is accredited by the Community Health Accreditation Program (CHAP) for high standards of excellence in medical staffing, private duty nursing, durable medical equipment and specialized pharmacy services. AmeriCare Medical, Inc. is the parent company of AmeriStaff Nursing Services, Sun Medical Equipment Company, and Rx iV Infusion Pharmacy, making it a one-stop resource for patients and their home care needs.

For more information, visit http://www.americaremedical.com/

Share article on social media or email: